Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CP 376395 (CP-316311)是一种 CRF1受体选择性拮抗剂。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 397 | 现货 | ||
2 mg | ¥ 589 | 现货 | ||
5 mg | ¥ 997 | 现货 | ||
10 mg | ¥ 1,620 | 现货 | ||
25 mg | ¥ 3,390 | 现货 | ||
50 mg | ¥ 4,990 | 现货 | ||
100 mg | ¥ 6,960 | 现货 | ||
500 mg | ¥ 14,200 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 1,070 | 现货 |
产品描述 | CP 376395 (CP-316311) is an effective and specific Corticotropin-releasing factor 1 (CRF1) receptor antagonist. |
体外活性 | It is highly selective for the human CRF1 receptor subtype,and exhibits affinities against 40 neurotransmitter receptor and ion channels(>1 μM). |
体内活性 | Pretreatment with CP 376395 (ID50=17.8 mg/kg, p.o.) reverses the excitation of locus coeruleus neurons induced by icv CRF (3 μg) completely blocked the enhanced startle response, while pretreatment with CP 376395(10 mg/kg, p.o.) induced by icv CRF (1 μg) is partially blocked. |
激酶实验 | In supernatants from cells, which are incubated in OSS_128167 (100 μM) for 18 hours,TNF-a levels are measured . |
动物实验 | Beagle dogs weighing between 8 and 15 kg are administered with CP 376395 hydrochloride salt (1.0 mg/kg) into the cephalic vein of the foreleg. Beagle dogs are treated with CP 376395(10 mg/mL) prepared in 0.1% methyl cellulose at pH 2 by oral. |
别名 | CP-316311 |
分子量 | 326.48 |
分子式 | C21H30N2O |
CAS No. | 175140-00-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: < 0.1 mg/mL (insoluble)
DMSO: 100 mg/mL (306.30 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 3.063 mL | 15.3149 mL | 30.6297 mL | 76.5744 mL |
5 mM | 0.6126 mL | 3.063 mL | 6.1259 mL | 15.3149 mL | |
10 mM | 0.3063 mL | 1.5315 mL | 3.063 mL | 7.6574 mL | |
20 mM | 0.1531 mL | 0.7657 mL | 1.5315 mL | 3.8287 mL | |
50 mM | 0.0613 mL | 0.3063 mL | 0.6126 mL | 1.5315 mL | |
100 mM | 0.0306 mL | 0.1531 mL | 0.3063 mL | 0.7657 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
CP 376395 175140-00-8 GPCR/G Protein CRFR inhibit CP 316311 CP-376395 CP316311 Inhibitor Corticotropin-releasing Factor Receptor CP376395 CP-316311 inhibitor